Literature DB >> 23816944

Usefulness of PET/CT for the differentiation and characterization of periampullary lesions.

Mei-Fang Cheng1, Hsiu-Po Wang, Yu-Wen Tien, Kao-Lang Liu, Rouh-Fang Yen, Kai-Yuan Tzen, Yen-Wen Wu.   

Abstract

PURPOSE: At present, there is no ideal imaging modality for the diagnosis of periampullary lesions. We prospectively evaluated the preoperative diagnostic usefulness of PET/CT for differentiating malignant from benign periampullary lesions.
METHODS: A total of 62 patients aged 27-86 years with periampullary lesions scheduled for surgical resection were consecutively recruited. Dual-phase (18)F-FDG PET/CT was performed in all patients. An additional 3'-deoxy-3'-[(18)F]fluorothymidine (FLT) scan was performed in 21 patients (33.9%). The relationship of visual interpretation, SUV, and lesion to background ratio (LBR) with surgical histopathology diagnosis was evaluated.
RESULTS: There were 36 patients with malignancies, 15 with benign neoplasms, and 11 with benign non-neoplasms. Using visual analysis, FDG PET/CT had good sensitivity (86.1%; 31/36), lower specificity (57.7%; 15/26), and fair accuracy (74.2%; 46/62). Regional lymph node metastases were identified in 7 of 11 patients by FDG PET/CT and only in 1 patient by abdominal CT. On the other hand, hepatic metastasis was detected in 1 patient by FDG PET/CT. Dual-phase FDG (P < 0.001) and FLT (P < 0.05) SUV(max) and LBR were significantly higher in malignant than in benign lesions, and in malignant neoplasms than in benign neoplasms. Although average FLT SUV(max) was significantly lower than the average FDG SUV(max) (P < 0.001), the specificity and accuracy of the former were significantly better.
CONCLUSION: FDG PET/CT may help identify patients with periampullary malignancy. FDG SUV(max) and LBR appear to aid in the differential diagnosis and add diagnostic confidence. In addition, higher specificity and diagnostic accuracy may be achieved by additional FLT PET/CT.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23816944     DOI: 10.1097/RLU.0b013e31829b266a

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Prospective comparison of (4S)-4-(3-18F-fluoropropyl)-L-glutamate versus 18F-fluorodeoxyglucose PET/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of-concept study.

Authors:  Mei-Fang Cheng; Ya-Yao Huang; Bing-Ying Ho; Ting-Chun Kuo; Ling-Wei Hsin; Chyng-Yann Shiue; Hsun-Chuan Kuo; Yung-Ming Jeng; Rouh-Fang Yen; Yu-Wen Tien
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-11       Impact factor: 9.236

2.  Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma.

Authors:  Pei-Ju Chuang; Hsiu-Po Wang; Yu-Jen Lin; Chieh-Chang Chen; Yu-Wen Tien; Min-Shu Hsieh; Shih-Hung Yang; Ruoh-Fang Yen; Chi-Lun Ko; Yen-Wen Wu; Mei-Fang Cheng
Journal:  Eur Radiol       Date:  2021-04-17       Impact factor: 5.315

Review 3.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

4.  Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.

Authors:  Hye Jin Choi; Chang Moo Kang; Kwanhyeong Jo; Woo Jung Lee; Jae-Hoon Lee; Young Hoon Ryu; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-13       Impact factor: 9.236

5.  Evaluation of the clinical and economic impact of delays to surgery in patients with periampullary cancer.

Authors:  R Pandé; J Hodson; A Murray; F Marcon; M Kalisvaart; R Marudanayagam; R P Sutcliffe; D F Mirza; J Isaac; K J Roberts
Journal:  BJS Open       Date:  2019-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.